All posts tagged "Eugene Shenderov;Johns Hopkins Kimmel Cancer Center;Bloomberg Kimmel Institute for Cancer Immunotherapy;enoblitzumab;Prostate Cancer;Immunotherapy"

Novel Immunotherapy Agent Safe, Shows Promise Against High-Risk Prostate Cancers

[ad_1] Newswise — A new drug, a monoclonal antibody known as enoblituzumab, is safe in men with aggressive prostate cancer and may induce clinical activity against...